Levetiracetam 102767-28-2

98% up by HPLC, USP/ EP/ CEP DMF, GMP

Product categories

New Products

Product Details

Product Information

Product name	Levetiracetam
CAS No.	102767-28-2
Molecular Formula	C4H11NO
Molecular Weight	170.211
Quality Standard	98% up by HPLC
Appearance	White or almost white powder

COA

ANALYSIS	SPECIFICATION	RESULTS
Appearance	White or almost white powder	White powder
Assay	98.0% - 102.0%	99.2%
Water	≤ 0.5%	≤ 0.1%
Residue on ignition	≤ 0.1%	≤ 0.1%
Heavy metals	≤ 20ppm	< 20ppm
Enantiomeric purity	≤ 0.8%	Not detected
Conclusion	The sample complies with the USP standard.

Usage

Levetiracetam is a medication primarily used to treat certain types of seizures in patients with epilepsy. It is a white crystalline powder with a specific chemical structure, namely (S)-α-ethyl-2-oxo-1-pyrrolidine acetamide, and has a molecular formula of C8H14N2O2.

Levetiracetam functions primarily as an anticonvulsant drug, which means it is designed to prevent or reduce the frequency and severity of seizures in patients with epilepsy. The exact mechanism of action of Levetiracetam is believed to work by binding to a protein called synaptic vesicle protein 2A (SV2A) located in the presynaptic terminal of neurons. This binding is thought to interfere with the release of neurotransmitters, specifically glutamate, which is involved in the generation and spread of seizures. By modulating glutamate release, Levetiracetam can reduce the likelihood of seizures occurring.

*Products under the patent are only for R&D use